Prosecution Insights
Last updated: April 19, 2026

Takeda Pharmaceutical Company Limited

6 pending office actions • 1 client

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Client Portfolio (1 client)

Client (Assignee)Pending OAs
Takeda Pharmaceutical Company Limited 6

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18039137 FLUID DELIVERY SYSTEM CONTAINER AND METHOD OF USE Takeda Pharmaceutical Company Limited FARRAR, LAUREN PENG 3783 Non-Final OA May 26, 2023
18037834 FLUID DELIVERY DEVICES AND METHODS THEREOF Takeda Pharmaceutical Company Limited LANGE, ERIC A 3783 Non-Final OA May 19, 2023
17995615 NEEDLE CONNECTORS AND MODULAR NEEDLE CONNECTORS FOR MULTI-DOSE DRUG DELIVERY DEVICES AND METHODS THEREOF Takeda Pharmaceutical Company Limited GRASMEDER, SARAH DYMPNA 3783 Non-Final OA Oct 06, 2022
17916441 ADAMTS13 VARIANT, COMPOSITIONS, AND USES THEREOF Takeda Pharmaceutical Company Limited ROBINSON, HOPE A 1652 Final Rejection Sep 30, 2022
17622044 ADENO-ASSOCIATED VIRUS PURIFICATION METHODS Takeda Pharmaceutical Company Limited SIFFORD, JEFFREY MARK 1671 Non-Final OA Dec 22, 2021
17264720 FORMULATIONS FOR IMPROVED STABILITY OF RECOMBINANT HUMAN PARATHYROID HORMONE Takeda Pharmaceutical Company Limited COFFA, SERGIO 1658 Final Rejection Jan 29, 2021

Managing Takeda Pharmaceutical Company Limited's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month